4//SEC Filing
Eisenstadt Richard I 4
Accession 0001104659-24-009538
CIK 0001326190other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:00 PM ET
Size
11.2 KB
Accession
0001104659-24-009538
Insider Transaction Report
Form 4
Eisenstadt Richard I
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001
2024-01-31$2.69/sh+4,621$12,430→ 45,012 total - Exercise/Conversion
Common Stock, par value $0.0001
2024-01-30+9,275→ 42,566 total - Exercise/Conversion
Restricted Stock Units
2024-01-30−9,275→ 27,825 total→ Common Stock, par value $0.0001 (9,275 underlying) - Tax Payment
Common Stock, par value $0.0001
2024-01-30$9.80/sh−2,175$21,315→ 40,391 total
Footnotes (5)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
- [F2]Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
- [F3]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2023 through January 31, 2024.
- [F4]In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2023.
- [F5]The RSUs become vested in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001515806
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 6:00 PM ET
- Size
- 11.2 KB